Vinod K. Fernando Perazzini Facchini et al. Em uma coorte de Um tremendo sucesso!
|Published (Last):||14 December 2004|
|PDF File Size:||6.1 Mb|
|ePub File Size:||20.76 Mb|
|Price:||Free* [*Free Regsitration Required]|
Citas 1. Incidence, course and prediction of hyperbilirrubinemia in near —term and term newborns. Diagnosis and management of hyperbilirubinemia in the term neonate: for a safe first week. Pediatr Clin North Am. Watchko JF. Kernicterus and the molecular mechanism of bilirubin induced CNS injury in newborns. Neuromolecular Med. Mancuso C. Bilirubin and brain: a pharmacological approach. Neuro Pharm. Calculates free bilirubin levels and neurotoxicity.
J Perinatol. Robertson A, Brodersen R. Effect of drug combination on bilirubin —albumin binding. Dev Pharmacol Ther. Watchko JF, Tiribelli C. Bilirubin —induced neurologic damage-Mechanism and management approaches.
N Engl J Med. Brites D. The evolving landscape of neurotoxicity by uncongugates bilirubin :role of glial cells and inflamation. Front Pharmacol. Cross — talk between neurons and astrocytes in response to bilirubin: early beneficial effects. Neurochem Res. Cross — talk between neurons and astrocytes in response to bilirubin : adverse secundary impacts. Neurotox Res. From the Centers for Diseases Control and Prevention. Kernicterus in full-term infants—United States, Johnson L, Bhutyani VK.
Guidelines for management of the jaundice in term and near term infants. Clin Perinatol. Evidence suggest there was not a resurgence of Kernicterus in the s. American Academy of Pediatrics. Provisional committee for quality improvement and subcommittee on hyperbilirubinemia practice parameter: management of hyperbilirubinemia in the healthy term newborn.
Subcomittee on hyperbilirubinemia in the newborn infants 35 p more weeks of gestation. Kernicterus: epidemiological strategies for the prevention through systems-based approaches. Risk factors from neonatal mortality in regional tertiary hospital in Nigeria. Niger J Clin Pract. Why is Kernicterus still a mayor cause of death and disability in low — income and middle-income countries.
Arch Dis Child. Wolff M, Aronson S. Management of neonates with hyperbilirubinemia improving timeliness of care using a clinical pathway. Ital J Pediar. National guidelines for treatment of jaundice in the newborn. Acta Paediatrica. Predictive ability of a predischarge hour specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near term newborn. Bilirubin screening for normal newborn: a critique of the hour specific bilirubin nomogram.
Prevent chronic bilirubin encephalopathy. Medical education required for Kernicterus risk recognition. Iran J Pediatr. Bhutani VK, Jhonson L. Incidence and causes of severe neonatal hyperbilirubinemiain Canada.
Extreme hyperbilirubinemia in term and near term infants in Denmark. Acta Paediatr. Hansen TWR. Prevention of neurodevelopmental sequelae of jaundice in the newborn. Dev Med Child Neurol. Clinical and genetic risk factors for moderate hyperbilirubinemia in Brazilian newborn infants.
Rev Med Chile. Shapiro SM. Chronic bilirubin encephalopathy: diagnosis and outcome. Sem Fetal Neonatal Med.
Auditory impairment in infants at risk for bilirubin —induced neurologic dysfunction. Sem Perinatol. Bhutani VK, Johnson L. Kernicterus en the 21st century: frequently asked questions. Incidence of hipoacusia secundary ti hyperbilirubinaemia in a universal neonatal auditory screening programme base don otoacusticemission and evoked auditory potentials. Acta Otorrinolaringol Esp. A modified bilirubin-induced neurologic dysfunction BIND-M algorithmis useful in evaluating severity of jaundice in resource limited setting.
BMC Pediatrics. Acta Pediatr. Auditory neuropaty spectrum disorder in late preterm and term infants with severe jaudice.
Int J Otorhinolaryngol. MRI findings in Kernicterus. Ind J Pediatr. Yilmaz Y, Ekinci G. Thalamic involvement in a patient with kernicterus. Eur Radiol. Changes in the globus pallidus in chronic kernicterus. J Pediatr Neurosci. Every newborn: progress, priorities and potential beyond survival.
Risk factors for severe neonatal hyoperbilirubinemia in low and middle income countries: a systematic review and Meta — analysis. PLoS One. Neonatal hyperbilirubinemia and rhesus diseases of the newborn: incidencia and impairment estimates for regional and global levels.
Pediatr Res. Mesquita, M.
Citas 1. Incidence, course and prediction of hyperbilirrubinemia in near —term and term newborns. Diagnosis and management of hyperbilirubinemia in the term neonate: for a safe first week. Pediatr Clin North Am. Watchko JF. Kernicterus and the molecular mechanism of bilirubin induced CNS injury in newborns.